(Q37143619)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18426514%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

review article

1 reference

title

The endocannabinoid system and the control of glucose homeostasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18426514%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

main subject

glycobiology

0 references

endocannabinoid system

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18426514%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

F Rohner-Jeanrenaud

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18426514%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

S C Woods

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18426514%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

M H Tschöp

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18426514%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

language of work or name

1 reference

1 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18426514%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroendocrinology

6 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18426514%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

20 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18426514%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

147-151

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18426514%20AND%20SRC:MED&resulttype=core&format=json

The emerging role of the endocannabinoid system in endocrine regulation and energy balance

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

Endocannabinoid control of food intake and energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

Endocannabinoids and the control of energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

Fighting obesity and associated risk factors by antagonising cannabinoid type 1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

Cannabinoid CB1 receptors in the paraventricular nucleus and central control of penile erection: immunocytochemistry, autoradiography and behavioral studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

Activation of the peripheral endocannabinoid system in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

AdipoQ is a novel adipose-specific gene dysregulated in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

Activation of cannabinoid CB1 receptors induces glucose intolerance in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

The adipocyte as an active participant in energy balance and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2008.01692.X